# LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS
> **NDA200793** · New Drug Application · Sponsor: MATRIX LABS · Approved 2010-07-08
## Drug
- **FDA Application Number:** NDA200793
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS
- **Generic name:** Lamivudine
- **Active ingredients:** Lamivudine; Nevirapine; Zidovudine
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MATRIX LABS
- **First approval:** 2010-07-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200793)
---
*AI Analytics · CC0 1.0*